Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3267581000168111 | Abraxane (paclitaxel (as nanoparticle albumin-bound) 250 mg) powder for injection, 1 x 250 mg vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3267591000168114 | Abraxane 250 mg powder for injection, 1 vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Abraxane 250 mg powder for injection, 1 vial | Is a | paclitaxel (as nanoparticle albumin-bound) 250 mg injection, 1 vial | true | Inferred relationship | Some | ||
| Abraxane 250 mg powder for injection, 1 vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Abraxane 250 mg powder for injection, 1 vial | has TPUU | Abraxane 250 mg powder for injection, 250 mg vial | true | Inferred relationship | Some | 1 | |
| Abraxane 250 mg powder for injection, 1 vial | has TP | Abraxane | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Abraxane 250 mg powder for injection, 1 vial | Is a | True | Abraxane 250 mg powder for injection, 1 vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR